|
Volumn 32, Issue 3, 2011, Pages 167-174
|
Antituberculous drug-induced liver injury: current perspective.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
TUBERCULOSTATIC AGENT;
GENETICS;
HEPATITIS B;
HEPATITIS C;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOLOGY;
INCIDENCE;
LIVER FUNCTION TEST;
PREVALENCE;
PROGNOSIS;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
TOXIC HEPATITIS;
TUBERCULOSIS;
ANTITUBERCULAR AGENTS;
DRUG-INDUCED LIVER INJURY;
HEPATITIS B;
HEPATITIS C;
HIV INFECTIONS;
HUMANS;
INCIDENCE;
LIVER FUNCTION TESTS;
PREVALENCE;
PROGNOSIS;
RISK ASSESSMENT;
RISK FACTORS;
TUBERCULOSIS;
|
EID: 84859381198
PISSN: 0250636X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (46)
|
References (0)
|